CBIO
Crescent Biopharma, Inc. Common Stock
CBIO
CBIO
69 hedge funds and large institutions have $111M invested in Crescent Biopharma, Inc. Common Stock in 2024 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 24 increasing their positions, 9 reducing their positions, and 10 closing their positions.
Holders
69
Holders Change
+11
Holders Change %
+18.97%
% of All Funds
1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
21
Increased
24
Reduced
9
Closed
10
Calls
$3.4M
Puts
$1.95M
Net Calls
+$1.45M
Net Calls Change
+$1.14M